Search Results - "Purroy, F"

Brain imaging in patients with transient ischemic attack by Purroy, F

Get full text

Lipidomic signature of stroke recurrence after transient ischemic attack by Purroy, F., Ois, A., Jove, M., Arque, G., Sol, J., Mauri-Capdevila, G., Rodriguez-Campello, A., Pamplona, R., Portero, M., Roquer, J.

“…While TIA patients have transient symptoms, they should not be underestimated, as they could have an underlying pathology that may lead to a subsequent stroke:…”
Get full text

Outcomes After Direct Thrombectomy or Combined Intravenous and Endovascular Treatment Are Not Different by Abilleira, Sònia, Ribera, Aida, Cardona, Pedro, Rubiera, Marta, López-Cancio, Elena, Amaro, Sergi, Rodríguez-Campello, Ana, Camps-Renom, Pol, Cánovas, David, de Miquel, Maria Angels, Tomasello, Alejandro, Remollo, Sebastian, López-Rueda, Antonio, Vivas, Elio, Perendreu, Joan, Gallofré, Miquel, Martí-Fàbregas, J, Delgado-Mederos, R, Martínez-Domeño, A, Marín, R, Roquer, J, Ois, Á, Jiménez-Conde, J, Guimaraens, L, Chamorro, Á, Obach, V, Urra, X, Macho, J.M, Blasco, J, San Roman, L, Martínez-Yélamos, A, Quesada, H, Lara, B, Cayuela, N, Aja, L, Mora, P, Molina, C, Ribó, M, Pagola, J, Rodríguez-Luna, D, Muchada, M, Coscojuela, P, Dávalos, A, Millán, M, Pérez de la Ossa, N, Gomis, M, Dorado, L, Castaño, C, Garcia, M.C, Estela, J, Krupinski, J, Huertas-Folch, S, Nicolás-Herrerias, M.C, Gómez-Choco, M, García, S, Martínez, R, Sanahuja, J, Purroy, F, Serena, J, Castellanos, M, Silva, Y, Marés, R, Pellisé, A, Ustrell, X, Baiges, J.J, Garcés, M, Saura, J, Soler-Insa, J.M, Aragonés, J.M, Cocho, D, Palomeras, E

“…BACKGROUND AND PURPOSE—Whether intravenous thrombolysis adds a further benefit when given before endovascular thrombectomy (EVT) is unknown. Furthermore,…”
Get full text

Assessment of incidence and trends in cerebrovascular disease in the healthcare district of Lleida (Spain) in the period 2010-2014 by Vena, A B, Cabré, X, Piñol, R, Molina, J, Purroy, F

“…OBJECTIVESThis study aimed to determine the incidence and trends of cerebrovascular disease (CVD) in the healthcare district of Lleida.MATERIAL AND METHODSWe…”
Get full text

Assessment of incidence and trends in cerebrovascular disease in the healthcare district of Lleida (Spain) in the period 2010–2014 by Vena, A.B., Cabré, X., Piñol, R., Molina, J., Purroy, F.

“…This study aimed to determine the incidence and trends of cerebrovascular disease (CVD) in the healthcare district of Lleida. We performed a population-based…”
Get full text

Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: A multicenter study by GILES, M. F, ALBERS, G. W, JOHNSTON, S. C, KELLY, P. J, KIM, A. S, LABREUCHE, J, LAVALLEE, P. C, MAS, J.-L, MERWICK, A, OLIVOT, J. M, PURROY, F, ROSAMOND, W. D, AMARENCO, P, SCIOLLA, R, ROTHWELL, P. M, ARSAVA, E. M, ASIMOS, A. W, AY, H, CALVET, D, COUTTS, S. B, CUCCHIARA, B. L, DEMCHUK, A. M

“…Stroke risk immediately after TIA defined by time-based criteria is high, and prognostic scores (ABCD2 and ABCD3-I) have been developed to assist management…”
Get full text

The influence of organisational management on door-to-needle times for fibrinolytic treatment by Vicente-Pascual, M, Quilez, A, Gil, M P, González-Mingot, C, Vázquez-Justes, D, Mauri-Capdevila, G, Sanahuja, J, García-Vázquez, C, Purroy, F

“…Door-to-needle time (DNT) has been established as the main indicator in code stroke protocols. According to the 2018 guidelines of the American Heart…”
Get full text

Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance by Gil-Núñez, A, Masjuan, J, Montaner, J, Castellanos, M, Segura, T, Cardona, P, Tembl, J I, Purroy, F, Arenillas, J, Palacio, E

“…INTRODUCTIONPatients with history of stroke or transient ischaemic attack present considerable risk of future vascular events. Reducing levels of low-density…”
Get full text

Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: a comparison of prognostic risk scores by Purroy, F, Jiménez Caballero, P E, Gorospe, A, Torres, M J, Alvarez-Sabin, J, Santamarina, E, Martínez-Sánchez, P, Cánovas, D, Freijo, M M, Egido, J A, Girón, J M, Ramírez-Moreno, J M, Alonso, A, Rodríguez-Campello, A, Casado, I, Delgado-Medeiros, R, Martí-Fàbregas, J, Fuentes, B, Silva, Y, Quesada, H, Cardona, P, Morales, A, de la Ossa, N, García-Pastor, A, Arenillas, J F, Segura, T, Jiménez, C, Masjuán, J

“…Several clinical scales have been developed for predicting stroke recurrence. These clinical scores could be extremely useful to guide triage decisions. Our…”
Get more information

Level of understanding of Alzheimer disease among caregivers and the general population by Jorge, C., Cetó, M., Arias, A., Blasco, E., Gil, M.P., López, R., Dakterzada, F., Purroy, F., Piñol-Ripoll, G.

“…Understanding of Alzheimer disease (AD) is fundamental for early diagnosis and to reduce caregiver burden. The objective of this study is to evaluate the…”
Get full text

Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project by Sánchez, E., Lecube, A., Betriu, À., Hernández, C., López-Cano, C., Gutiérrez-Carrasquilla, L., Kerkeni, M., Yeramian, A., Purroy, F., Pamplona, R., Farràs, C., Fernández, E., Barbé, F., Simó, R., Hernández, M., Rius, F., Polanco, D., de la Torre, M.S., Torres, G., Godoy, P., Portero-Otin, M., Jové, M., Colàs-Compàs, L., Benabdelhak, I., Miquel, E., Ortega, M., Valdivielso, J.M., Bermúdez, M., Martínez-Alonso, M.

Get full text

Reperfusion therapy in acute ischaemic stroke due to cervical and cerebral artery dissection: Results from a Spanish multicentre study by Campo-Caballero, D., de la Riva, P., de Arce, A., Martínez-Zabaleta, M., Rodríguez-Antigüedad, J., Ekiza, J., Iruzubieta, P., Purroy, F., Fuentes, B., de Lera Alfonso, M., Krupinski, J., Mengual Chirife, J.J., Palomeras, E., Guisado-Alonso, D., Rodríguez-Yáñez, M., Ustrell, X., Tejada García, J., de Felipe Mimbrera, A., Paré-Curell, M., Tembl, J., Cajaraville, S., Garcés, M., Serena, J.

“…Ischaemic stroke (IS) due to cervical and cerebral artery dissection (CAD) is a rare entity, and few data are available on the use of such reperfusion…”
Get full text

Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease by Masjuan, J., Gállego, J., Aguilera, J.M., Arenillas, J.F., Castellanos, M., Díaz, F., Portilla, J.C., Purroy, F.

“…There is little control of cardiovascular (CV) risk factors in secondary prevention after an ischaemic stroke, in part due to a lack of adherence to treatment…”
Get full text

Predictive value of brain and vascular imaging including intracranial vessels in transient ischaemic attack patients: external validation of the ABCD3-I score by Purroy, F., Jiménez-Caballero, P. E., Mauri-Capdevila, G., Torres, M. J., Gorospe, A., Ramírez Moreno, J. M., de la Ossa, N. P., Cánovas, D., Arenillas, J., Álvarez-Sabín, J., Martínez Sánchez, P., Fuentes, B., Delgado-Mederos, R., Martí-Fàbregas, J., Rodríguez Campello, A., Masjuán, J.

“…Background and purpose Recently, brain and vascular imaging have been added to clinical variables to identify patients with transient ischaemic attack (TIA)…”
Get full text

Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study by Campo-Caballero, D, de la Riva, P, de Arce, A, Martínez-Zabaleta, M, Rodríguez-Antigüedad, J, Ekiza, J, Iruzubieta, P, Purroy, F, Fuentes, B, de Lera Alfonso, M, Krupinski, J, Mengual Chirife, J J, Palomeras, E, Guisado-Alonso, D, Rodríguez-Yáñez, M, Ustrell, X, Tejada García, J, de Felipe Mimbrera, A, Paré-Curell, M, Tembl, J, Cajaraville, S, Garcés, M, Serena, J

“…Ischaemic stroke (IS) due to cervical and cerebral artery dissection (CAD) is a rare entity, and few data are available on the use of such reperfusion…”
Get full text

The influence of organisational management on door-to-needle times for fibrinolytic treatment by Vicente-Pascual, M., Quilez, A., Gil, M.P., González-Mingot, C., Vázquez-Justes, D., Mauri-Capdevila, G., Sanahuja, J., García-Vázquez, C., Purroy, F.

“…Door-to-needle time (DNT) has been established as the main indicator in code stroke protocols. According to the 2018 guidelines of the American Heart…”
Get full text

Incidental findings on brain MRI in a cohort of diabetic patients by Vázquez-Justes, D., Sanahuja, J., Diez, J., Rubinat, E., Begué, R., Salas, C., Vicandi, C., Gil, M.I., Purroy, F., Mauricio, D.

“…To study the frequency and management of incidental findings in nonenhanced brain MRI of a middle-aged population of type 2 diabetic patients. We…”
Get full text

Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease by Masjuan, J, Gállego, J, Aguilera, J M, Arenillas, J F, Castellanos, M, Díaz, F, Portilla, J C, Purroy, F

“…INTRODUCTIONThere is little control of cardiovascular (CV) risk factors in secondary prevention after an ischaemic stroke, in part due to a lack of adherence…”
Get full text

Plasma D-dimer predicts poor outcome after acute intracerebral hemorrhage by DELGADO, P, ALVAREZ-SABIN, J, ABILLEIRA, S, SANTAMARINA, E, PURROY, F, ARENILLAS, J. F, MOLINA, C. A, FERNANDEZ-CADENAS, I, ROSELL, A, MONTANER, J

“…To investigate if systemic d-dimer activation occurs after acute intracerebral hemorrhage (ICH) and to study its influence on clinical outcome. The authors…”
Get full text

The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation by Colàs-Campàs, L., Royo, J. L., Montserrat, M. V., Marzo, C., Molina-Seguín, J., Benabdelhak, I., Cambray, S., Purroy, F.

“…Oral anticoagulant treatments, such as vitamin K antagonists (VKAs), are the main treatments administered to atrial fibrillation (AF) patients in order to…”
Get full text